Process / pipelineClinical ResearchObservational designPipeline

Cohort Study Design

Also known as: prospective study, follow-up study, longitudinal study, cohort study

OriginatorDonald Acheson, Olli Miettinen, and others in modern epidemiologyYear1970s-1980sSources3Related methods7

A cohort study follows a group of individuals forward in time from exposure to outcome. Exposed and unexposed participants (or participants with differing exposure levels) are enrolled at baseline, characterized, and observed prospectively until the outcome occurs or the study ends. Cohort studies are fundamental to epidemiology and are the design of choice for establishing causal associations when randomized trials are infeasible or unethical.

Key highlights

  • Clear temporal sequence: exposure recorded before outcome, establishing directionality and causality more convincingly than cross-sectional designs.
  • Multiple outcomes: single exposure can be related to many outcomes, economical for broad hypothesis generation.
  • Incidence and absolute risk: directly estimates risk in exposed and unexposed groups, enabling calculation of number needed to treat.
  • Avoids outcome-dependent selection: cohort defined by exposure, not outcome, preventing selection bias inherent in case-control studies.
  • Incidence rates: person-time denominators account for variable follow-up, allowing comparison across studies with different follow-up durations.

Intuition

This section is available to Pro members. Upgrade to Pro

How it works

This section is available to Pro members. Upgrade to Pro

When to use it

Use cohort studies when: (1) studying rare exposures (e.g., occupational hazards affecting few people), (2) establishing temporal relationships between exposure and outcome, (3) studying multiple outcomes from a single exposure (e.g., smoking → cancer, heart disease, COPD), (4) evaluating long-term effects over years or decades, (5) assessing natural history and incidence of disease, (6) randomized trials are unethical (e.g., exposing people to harmful substances), (7) outcomes are common, making case-control less efficient.

Strengths & limitations

Strengths
  • Clear temporal sequence: exposure recorded before outcome, establishing directionality and causality more convincingly than cross-sectional designs.
  • Multiple outcomes: single exposure can be related to many outcomes, economical for broad hypothesis generation.
  • Incidence and absolute risk: directly estimates risk in exposed and unexposed groups, enabling calculation of number needed to treat.
  • Avoids outcome-dependent selection: cohort defined by exposure, not outcome, preventing selection bias inherent in case-control studies.
  • Incidence rates: person-time denominators account for variable follow-up, allowing comparison across studies with different follow-up durations.
Limitations
  • Time and cost: following cohorts for years or decades requires sustained funding, staff, and infrastructure; attrition (loss to follow-up) is common.
  • Loss to follow-up bias: if participants lost are systematically different on exposure or confounders, RR estimates become biased. Requires high follow-up rates (>80%).
  • Rare outcomes: if outcome incidence is very low, huge cohorts are needed, increasing cost. Case-control may be more efficient.
  • Confounding: unmeasured or poorly measured confounders can bias RR. Adjustment is limited to measured variables.
  • Cohort effects: participants enrolled over time may differ in baseline characteristics, prognosis, or secular trends, affecting comparability.

Common pitfalls

This section is available to Pro members. Upgrade to Pro

Applications

This section is available to Pro members. Upgrade to Pro

Frequently asked

What is the difference between Relative Risk (RR) and Odds Ratio (OR) in a cohort study?

In cohort studies, you directly measure incidence (probability of outcome over time), so Relative Risk (RR) is the natural estimate: RR = Incidence_exposed / Incidence_unexposed. Odds Ratio (OR) is the ratio of odds of outcome; it arises in case-control studies where you cannot measure incidence. In cohorts with rare outcomes (incidence <10%), RR and OR approximate each other. When outcomes are common, they diverge: OR overstates the effect compared to RR. Always report RR in cohort studies; reserve OR for case-control designs.

What is person-time, and why does it matter?

Person-time (or follow-up time) is the sum of individual follow-up durations. If you follow 100 people for 10 years each, that is 1000 person-years. If 50 people are followed 5 years and 50 people 10 years, that is also 750 person-years. Incidence rate is calculated per person-time unit (e.g., per 1000 person-years). Person-time accounts for the fact that some participants drop out, die, or are censored early. Using person-time as the denominator (rather than just the number of people) gives unbiased estimates when follow-up is variable.

How do I handle loss to follow-up?

Loss to follow-up is a major source of bias. Aim for >80% follow-up. In analysis, do not simply exclude those lost; this introduces selection bias. Instead, use intention-to-treat logic: classify lost participants by their last known status, and perform sensitivity analyses assuming different outcome scenarios (e.g., all lost are outcome-free, all lost developed outcome, or missing at random). If loss-to-follow-up differs markedly between exposed and unexposed groups, interpret results with caution. Inverse probability weighting (IPW) or multiple imputation can adjust for systematic missingness under the 'missing at random' assumption.

How do I distinguish between cohort and cross-sectional studies?

A cohort study enrolls disease-free (or outcome-free) participants, measures exposure at baseline, and follows them forward until outcome occurs. A cross-sectional study measures exposure and outcome simultaneously at a single point in time, capturing prevalence. Cohorts have clear temporal sequence (exposure → outcome), enabling causal inference. Cross-sectional studies cannot establish directionality: did exposure cause outcome, or did outcome influence exposure perception? Cohorts are more costly and time-consuming but provide stronger evidence for causality.

Sources

  1. 1.
    Miettinen, O. S. (1976). Estimability and estimation in case-referent studies. American Journal of Epidemiology, 103(2), 226–235.
  2. 2.
    Rothman, K. J., Lash, T. L., & Greenland, S. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins.
    ISBN 978-0781755657
  3. 3.
    Veierød, M. B., Lydersen, S., & Laake, P. (2012). Medical Statistics in Clinical and Epidemiological Research. Gyldendal Akademisk.
    ISBN 978-8205418627

You have read it. What now?

Cite this page

ScholarGate. (2026, June 4). Cohort Study Design. ScholarGate. https://scholargate.app/clinical-research/cohort-study-design

Cohort Study Design — Prospective Cohort Study | ScholarGate